Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Nov;116(6):2691–2697. doi: 10.1111/j.1476-5381.1995.tb17228.x

Functional coupling between A1 adenosine receptors and G-proteins in rat hippocampal membranes assessed by high-affinity GTPase activity.

Y Odagaki 1, K Fuxe 1
PMCID: PMC1909133  PMID: 8590991

Abstract

1. In order to investigate the functional interaction between adenosine receptors and G-proteins in native brain membranes, stimulation of high-affinity GTPase activity by adenosine receptor agonists was characterized in rat hippocampal membranes. 2. Addition of 1 microM R-N6-phenylisopropyladenosine (R-PIA), a selective A1 adenosine receptor agonist, augmented the Vmax of the low-KM GTPase by 51%, with a slight increase in the KM value. 3. Several adenosine receptor agonists stimulated the high-affinity GTPase activity in a concentration-dependent manner, with a rank order of potency indicative of the involvement of A1 adenosine receptor subtype as follows: R-PIA > N6-cyclohexyladenosine > 5'-N-ethylcarboxamidoadenosine > or = 2-chloroadenosine > S-PIA > CGS 21680, 2-phenylaminoadenosine. 4. The selective A1 adenosine receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine, inhibited R-PIA-stimulated high-affinity GTPase activity in a competitive manner, with a KB value of 2.5 nM. 5. The activating effects on high-affinity GTPase of R-PIA (via A1 adenosine receptors) and of 5-HT (via 5-HT1A receptors) were completely additive, indicating that A1 adenosine and 5-HT1A receptors were coupled to distinct pools of G-proteins in hippocampus. 6. Stimulation of high-affinity GTPase activity by adenosine receptor agonists can be used as a valuable measure for the investigation of the functional coupling between A1 adenosine receptors and G-proteins associated with adenylyl cyclase inhibition.

Full text

PDF
2691

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aktories K., Schultz G., Jakobs K. H. Adenosine receptor-mediated stimulation of GTP hydrolysis in adipocyte membranes. Life Sci. 1982 Jan 18;30(3):269–275. doi: 10.1016/0024-3205(82)90508-2. [DOI] [PubMed] [Google Scholar]
  3. Bruns R. F., Lu G. H., Pugsley T. A. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol. 1986 Apr;29(4):331–346. [PubMed] [Google Scholar]
  4. Collis M. G., Hourani S. M. Adenosine receptor subtypes. Trends Pharmacol Sci. 1993 Oct;14(10):360–366. doi: 10.1016/0165-6147(93)90094-z. [DOI] [PubMed] [Google Scholar]
  5. Dolphin A. C., Prestwich S. A. Pertussis toxin reverses adenosine inhibition of neuronal glutamate release. Nature. 1985 Jul 11;316(6024):148–150. doi: 10.1038/316148a0. [DOI] [PubMed] [Google Scholar]
  6. Dunwiddie T. V., Fredholm B. B. Adenosine modulation of synaptic responses in rat hippocampus: possible role of inhibition or activation of adenylate cyclase. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1985;19:259–272. [PubMed] [Google Scholar]
  7. Fredholm B. B., Abbracchio M. P., Burnstock G., Daly J. W., Harden T. K., Jacobson K. A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol Rev. 1994 Jun;46(2):143–156. [PMC free article] [PubMed] [Google Scholar]
  8. Fredholm B. B., Jonzon B., Lindström K. Adenosine receptor mediated increases and decreases in cyclic AMP in hippocampal slices treated with forskolin. Acta Physiol Scand. 1983 Mar;117(3):461–463. doi: 10.1111/j.1748-1716.1983.tb00022.x. [DOI] [PubMed] [Google Scholar]
  9. Fredholm B. B., Jonzon B., Lindström K. Effect of adenosine receptor agonists and other compounds on cyclic AMP accumulation in forskolin-treated hippocampal slices. Naunyn Schmiedebergs Arch Pharmacol. 1986 Feb;332(2):173–178. doi: 10.1007/BF00511409. [DOI] [PubMed] [Google Scholar]
  10. Freissmuth M., Selzer E., Schütz W. Interactions of purified bovine brain A1-adenosine receptors with G-proteins. Reciprocal modulation of agonist and antagonist binding. Biochem J. 1991 May 1;275(Pt 3):651–656. doi: 10.1042/bj2750651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gavish M., Goodman R. R., Snyder S. H. Solubilized adenosine receptors in the brain: regulation of guanine nucleotides. Science. 1982 Mar 26;215(4540):1633–1635. doi: 10.1126/science.6280275. [DOI] [PubMed] [Google Scholar]
  12. Goodman R. R., Cooper M. J., Gavish M., Snyder S. H. Guanine nucleotide and cation regulation of the binding of [3H]cyclohexyladenosine and [3H]diethylphenylxanthine to adenosine A1 receptors in brain membranes. Mol Pharmacol. 1982 Mar;21(2):329–335. [PubMed] [Google Scholar]
  13. Hausleithner V., Freissmuth M., Schütz W. Adenosine-receptor-mediated stimulation of low-Km GTPase in guinea-pig cerebral cortex. Biochem J. 1985 Dec 1;232(2):501–504. doi: 10.1042/bj2320501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hepler J. R., Gilman A. G. G proteins. Trends Biochem Sci. 1992 Oct;17(10):383–387. doi: 10.1016/0968-0004(92)90005-t. [DOI] [PubMed] [Google Scholar]
  15. Klotz K. N., Keil R., Zimmer F. J., Schwabe U. Guanine nucleotide effects on 8-cyclopentyl-1,3-[3H]dipropylxanthine binding to membrane-bound and solubilized A1 adenosine receptors of rat brain. J Neurochem. 1990 Jun;54(6):1988–1994. doi: 10.1111/j.1471-4159.1990.tb04902.x. [DOI] [PubMed] [Google Scholar]
  16. Klotz K. N., Lohse M. J., Schwabe U. Characterization of the solubilized A1 adenosine receptor from rat brain membranes. J Neurochem. 1986 May;46(5):1528–1534. doi: 10.1111/j.1471-4159.1986.tb01772.x. [DOI] [PubMed] [Google Scholar]
  17. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  18. Linden J. Structure and function of A1 adenosine receptors. FASEB J. 1991 Sep;5(12):2668–2676. doi: 10.1096/fasebj.5.12.1916091. [DOI] [PubMed] [Google Scholar]
  19. Lohse M. J., Lenschow V., Schwabe U. Two affinity states of Ri adenosine receptors in brain membranes. Analysis of guanine nucleotide and temperature effects on radioligand binding. Mol Pharmacol. 1984 Jul;26(1):1–9. [PubMed] [Google Scholar]
  20. Lorenzen A., Fuss M., Vogt H., Schwabe U. Measurement of guanine nucleotide-binding protein activation by A1 adenosine receptor agonists in bovine brain membranes: stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding. Mol Pharmacol. 1993 Jul;44(1):115–123. [PubMed] [Google Scholar]
  21. Milligan G. Techniques used in the identification and analysis of function of pertussis toxin-sensitive guanine nucleotide binding proteins. Biochem J. 1988 Oct 1;255(1):1–13. doi: 10.1042/bj2550001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Munshi R., Linden J. Interaction of purified bovine brain A1-adenosine receptors with guanine nucleotide-binding proteins of human platelet membranes following reconstitution. Mol Pharmacol. 1990 Aug;38(2):170–176. [PubMed] [Google Scholar]
  23. Munshi R., Pang I. H., Sternweis P. C., Linden J. A1 adenosine receptors of bovine brain couple to guanine nucleotide-binding proteins Gi1, Gi2, and Go. J Biol Chem. 1991 Nov 25;266(33):22285–22289. [PubMed] [Google Scholar]
  24. Odagaki Y., Fuxe K. 5-HT1A receptor-mediated activation of high-affinity GTPase in rat hippocampal membranes. Eur J Pharmacol. 1995 Feb 15;288(3):385–388. doi: 10.1016/0922-4106(95)90053-5. [DOI] [PubMed] [Google Scholar]
  25. Odagaki Y., Fuxe K. 5-HT1A, GABAB, and pirenzepine-insensitive muscarinic receptors are functionally coupled to distinct pools of the same kind of G proteins in rat hippocampus. Brain Res. 1995 Aug 14;689(1):129–135. doi: 10.1016/0006-8993(95)00576-c. [DOI] [PubMed] [Google Scholar]
  26. Odagaki Y., Fuxe K. Functional coupling of dopamine D2 and muscarinic cholinergic receptors to their respective G proteins assessed by agonist-induced activation of high-affinity GTPase activity in rat striatal membranes. Biochem Pharmacol. 1995 Jul 31;50(3):325–335. doi: 10.1016/0006-2952(95)00146-q. [DOI] [PubMed] [Google Scholar]
  27. Olsson R. A., Pearson J. D. Cardiovascular purinoceptors. Physiol Rev. 1990 Jul;70(3):761–845. doi: 10.1152/physrev.1990.70.3.761. [DOI] [PubMed] [Google Scholar]
  28. Ramkumar V., Stiles G. L. Reciprocal modulation of agonist and antagonist binding to A1 adenosine receptors by guanine nucleotides is mediated via a pertussis toxin-sensitive G protein. J Pharmacol Exp Ther. 1988 Sep;246(3):1194–1200. [PubMed] [Google Scholar]
  29. Stiles G. L. A1 adenosine receptor-G protein coupling in bovine brain membranes: effects of guanine nucleotides, salt, and solubilization. J Neurochem. 1988 Nov;51(5):1592–1598. doi: 10.1111/j.1471-4159.1988.tb01129.x. [DOI] [PubMed] [Google Scholar]
  30. Williams M., Braunwalder A. Effects of purine nucleotides on the binding of [3H]cyclopentyladenosine to adenosine A-1 receptors in rat brain membranes. J Neurochem. 1986 Jul;47(1):88–97. doi: 10.1111/j.1471-4159.1986.tb02835.x. [DOI] [PubMed] [Google Scholar]
  31. Wojcik W. J., Cavalla D., Neff N. H. Co-localized adenosine A1 and gamma-aminobutyric acid B (GABAB) receptors of cerebellum may share a common adenylate cyclase catalytic unit. J Pharmacol Exp Ther. 1985 Jan;232(1):62–66. [PubMed] [Google Scholar]
  32. Yeung S. M., Green R. D. Agonist and antagonist affinities for inhibitory adenosine receptors are reciprocally affected by 5'-guanylylimidodiphosphate or N-ethylmaleimide. J Biol Chem. 1983 Feb 25;258(4):2334–2339. [PubMed] [Google Scholar]
  33. Zgombick J. M., Beck S. G., Mahle C. D., Craddock-Royal B., Maayani S. Pertussis toxin-sensitive guanine nucleotide-binding protein(S) couple adenosine A1 and 5-hydroxytryptamine1A receptors to the same effector systems in rat hippocampus: biochemical and electrophysiological studies. Mol Pharmacol. 1989 Apr;35(4):484–494. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES